Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Fresh Meadows, New York Clinical Trials

A listing of Fresh Meadows, New York clinical trials actively recruiting patient volunteers.

Found (397) clinical trials

Striatal Connectivity and Clinical Outcome in Psychosis

In this proposed study, the study will examine treatment-related effects on functional brain circuitry in first episode schizophrenia. Converging lines of evidence suggest a key role for striatal disconnectivity in the pathophysiology of psychosis. The proposed study will utilize resting state functional magnetic resonance imaging (rs-fMRI), as well as fMRI …

Phase N/A

4.44 miles

Learn More »

MammaPrint BluePrint and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

The FLEX Registry will include all patients with stage I-III breast cancer who have received MammaPrint and BluePrint testing in any clinical setting. Study arm appendices will specify treatment arm, inclusion criteria, and number of patients needed. Approximately 2000 patients from 70-75 US based institutions will be enrolled. Treatment is …

Phase N/A

4.66 miles

Learn More »

Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)

The purpose of the proposed study is to acquire additional data (including the assessment of anti-rHuPH20 antibodies) on the long-term safety of HYQVIA and to assess the prescribed treatment regimens and treatment administration in routine clinical practice.

Phase N/A

4.93 miles

Learn More »

A Long-Term Registry of Humira (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label.

Phase N/A

4.93 miles

Learn More »

Subjects will be evaluated via both in-clinic and at-home assessments. The in-clinic assessments are designed to compare the ability of current Parkinson disease clinical trial measures with the ability of mobile and wearable devices to detect disease progression in the early stage of disease. The at-home assessments are designed to …

Phase N/A

4.93 miles

Learn More »

Entyvio (Vedolizumab) Long Term Safety Study

The drug being tested in this prospective, observational study is called vedolizumab. Vedolizumab is being used to treat people who have UC or CD. This study will look at the long-term safety of vedolizumab versus other biologic agents in participants with UC or CD. The study will enroll approximately 5000 …

Phase N/A

4.93 miles

Learn More »

To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)

Prospective, observational study to evaluate the natural progression of anatomical and functional visual parameters in genetically defined subjects with GA due to AMD.

Phase N/A

4.93 miles

Learn More »

Clinical Utility of WATS3D: A 5-Year Prospective Study

This study will look at the impact of the brush biopsy results on your doctor's decisions about your future care and treatment. In addition , by recording the results of all your biopsies over 5 years, it may be possible to find out if the brush biopsy, forceps biopsy, or …

Phase N/A

5.35 miles

Learn More »

American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry

Rationale The rationale for creating this multi-center clinical database is to optimally collect clinical and pathological data on patients with neoplasms in order to facilitate future clinical observational and outcomes-based research. Inclusion Criteria Patients will be considered eligible for inclusion into the database if they meet the following eligibility criteria: …

Phase N/A

5.35 miles

Learn More »

Prospective Collection of PillCam SB3 Videos and Raw Data Files for Future Developments (SODA)

Up to 5000 PillCam SB3 videos (including PillCam reports) and raw data files will be collected in up to 25 medical centers in the US. Study duration is up to 3 years from IRB approval. Medical center study sites will provide relevant videos (including PillCam reports) and raw data from …

Phase N/A

5.35 miles

Learn More »